Bayer Schering Pharma Remains Optimistic About Growth In Asia Pacific Region, Won’t Join Acquisition Bandwagon
This article was originally published in PharmAsia News
Executive Summary
Bayer Schering Pharma has been enjoying double-digit growth in the Asia Pacific region for the past three years, and is confident in maintaining this momentum over the next few years, said Chris Lee, the company's Asia Pacific regional head. Bayer will expand its China workforce from the current 3,000 people to more than 4,000 people in the next two years. Lee said that the acquisition planned by Merck of Schering-Plough and by Pfizer of Wyeth will not pose a substantial threat to Bayer. He stressed that Bayer will not resort to an acquisition strategy as a counter-measure, and will instead rely on its strong R&D.(Click here for more - Chinese Language)